Alejandro Reyes

Alejandro (Alex) Reyes, MBA, is an accomplished healthcare professional with extensive experience in the rare disease sector. Currently serving as an Executive Rare Disease Clinical Specialist at Kiniksa Pharmaceuticals since September 2022, Alejandro has achieved back-to-back Circle of Excellence awards in 2023 and 2024 and successfully launched a biologic for Recurrent Pericarditis. Prior roles include Senior Key Account Manager at Zogenix, where Alejandro launched a product for Rare/Ultra Rare Pediatric Neurologic Syndromes, and Therapeutic Area Manager at Genentech, contributing to a highly successful launch of a biologic for Hemophilia B. With a solid foundation in marketing and sales from positions at Merck, Roche, and Durata Therapeutics, Alejandro holds an MBA in Healthcare Economics from the Quinlan School of Business, Loyola University Chicago, and a Bachelor's degree in Biology with a focus on Human Physiology from Northern Illinois University.